Literature DB >> 10811619

The sno gene, which encodes a component of the histone deacetylase complex, acts as a tumor suppressor in mice.

T Shinagawa1, H D Dong, M Xu, T Maekawa, S Ishii.   

Abstract

The Ski and Sno oncoproteins are components of a macromolecular complex containing the co-repressor N-CoR/SMRT, mSin3 and histone deacetylase. This complex has been implicated in the transcriptional repression exerted by a number of repressors including nuclear hormone receptors and Mad. Further more, Ski and Sno negatively regulate transforming growth factor-beta (TGF-beta) signaling by recruiting this complex to Smads. Here we show that loss of one copy of sno increases susceptibility to tumorigenesis in mice. Mice lacking sno died at an early stage of embryogenesis, and sno was required for blastocyst formation. Heterozygous (sno(+/-)) mice developed spontaneous lymphomas at a low frequency and showed an increased level of tumor formation relative to wild-type mice when challenged with a chemical carcinogen. sno(+/-) embryonic fibroblasts had an increased proliferative capacity and the introduction of activated Ki-ras into these cells resulted in neoplastic transformation. The B cells, T cells and embryonic fibroblasts of sno(+/-) mice had a decreased sensitivity to apoptosis or cell cycle arrest. These findings demonstrate that sno acts as a tumor suppressor at least in some types of cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10811619      PMCID: PMC384369          DOI: 10.1093/emboj/19.10.2280

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  64 in total

1.  Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression.

Authors:  L Alland; R Muhle; H Hou; J Potes; L Chin; N Schreiber-Agus; R A DePinho
Journal:  Nature       Date:  1997-05-01       Impact factor: 49.962

2.  Rb interacts with histone deacetylase to repress transcription.

Authors:  R X Luo; A A Postigo; D C Dean
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

3.  Retinoblastoma protein represses transcription by recruiting a histone deacetylase.

Authors:  L Magnaghi-Jaulin; R Groisman; I Naguibneva; P Robin; S Lorain; J P Le Villain; F Troalen; D Trouche; A Harel-Bellan
Journal:  Nature       Date:  1998-02-05       Impact factor: 49.962

4.  Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling.

Authors:  Y Sun; X Liu; E N Eaton; W S Lane; H F Lodish; R A Weinberg
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

5.  Role of PML in cell growth and the retinoic acid pathway.

Authors:  Z G Wang; L Delva; M Gaboli; R Rivi; M Giorgio; C Cordon-Cardo; F Grosveld; P P Pandolfi
Journal:  Science       Date:  1998-03-06       Impact factor: 47.728

6.  Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein-Taybi syndrome.

Authors:  Y Tanaka; I Naruse; T Maekawa; H Masuya; T Shiroishi; S Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

7.  c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads.

Authors:  S Akiyoshi; H Inoue; J Hanai; K Kusanagi; N Nemoto; K Miyazono; M Kawabata
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

8.  Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein.

Authors:  S L Stroschein; W Wang; S Zhou; Q Zhou; K Luo
Journal:  Science       Date:  1999-10-22       Impact factor: 47.728

9.  Transcriptional repression by v-Ski and c-Ski mediated by a specific DNA binding site.

Authors:  R Nicol; E Stavnezer
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

10.  Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development.

Authors:  M Berk; S Y Desai; H C Heyman; C Colmenares
Journal:  Genes Dev       Date:  1997-08-15       Impact factor: 11.361

View more
  36 in total

Review 1.  The Max network gone mad.

Authors:  T A Baudino; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN.

Authors:  S L Stroschein; S Bonni; J L Wrana; K Luo
Journal:  Genes Dev       Date:  2001-11-01       Impact factor: 11.361

3.  Regulation of gene expression by internal ribosome entry sites or cryptic promoters: the eIF4G story.

Authors:  Baoguang Han; Jian-Ting Zhang
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

4.  A direct intersection between p53 and transforming growth factor beta pathways targets chromatin modification and transcription repression of the alpha-fetoprotein gene.

Authors:  Deepti S Wilkinson; Stacey K Ogden; Sabrina A Stratton; Julie L Piechan; Thi T Nguyen; George A Smulian; Michelle Craig Barton
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

Review 5.  SnoN signaling in proliferating cells and postmitotic neurons.

Authors:  Shirin Bonni; Azad Bonni
Journal:  FEBS Lett       Date:  2012-03-08       Impact factor: 4.124

6.  The regulatory protein SnoN antagonizes activin/Smad2 protein signaling and thereby promotes adipocyte differentiation and obesity in mice.

Authors:  Qingwei Zhu; Amanda Chang; Albert Xu; Kunxin Luo
Journal:  J Biol Chem       Date:  2018-07-20       Impact factor: 5.157

7.  Dual role of SnoN in mammalian tumorigenesis.

Authors:  Qingwei Zhu; Ariel R Krakowski; Elizabeth E Dunham; Long Wang; Abhik Bandyopadhyay; Rebecca Berdeaux; G Steven Martin; LuZhe Sun; Kunxin Luo
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

8.  Defective T-cell activation is associated with augmented transforming growth factor Beta sensitivity in mice with mutations in the Sno gene.

Authors:  S Pearson-White; M McDuffie
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

9.  Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesis.

Authors:  Meera Nanjundan; Kwai Wa Cheng; Fan Zhang; John Lahad; Wen-Lin Kuo; Rosemarie Schmandt; Karen Smith-McCune; David Fishman; Joe W Gray; Gordon B Mills
Journal:  Mol Oncol       Date:  2008-05-10       Impact factor: 6.603

10.  Oncogene and tumour suppressor: the two faces of SnoN.

Authors:  Samy Lamouille; Rik Derynck
Journal:  EMBO J       Date:  2009-11-18       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.